19 February 2021 : Original article
Short- and Long-Term Outcomes of Different Reperfusion Sequences in Liver Transplantation
Ann-Kathrin Eichelmann1BCEF*, Thomas Vogel1ABE, Ann-Kathrin Fuchs1BC, Philipp Houben1DE, Shadi Katou1BDF, Felix Becker1CD, Hartmut H. Schmidt2AD, Christian Wilms2DF, Andreas Pascher1BD, Jens G. Brockmann1ACDEDOI: 10.12659/AOT.926847
Ann Transplant 2021; 26:e926847
Table 1 Recipient data.
| PV | A | SIM | p | |
|---|---|---|---|---|
| Age (y) | 49 (24–66) | 55 (31–66) | 59 (46–69) | 0.01 |
| Gender; Male: Female | 18: 7 | 12: 10 | 7: 7 | 0.3 |
| MELD | 17 (6–40) | 19 (6–40) | 22 (7–40) | 0.3 |
| Diagnosis | ||||
| Acute liver failure | 3 | 2 | 5 | 0.4 |
| Cirrhosis | 10 | 10 | 3 | |
| HCC | 8 | 8 | 4 | |
| Amyloidosis | 2 | 1 | 0 | |
| Polycystic liver disease | 2 | 1 | 2 | |
| PV – primary portal venous reperfusion; A – primary arterial reperfusion; SIM – simultaneous reperfusion; Y – years; MELD – model for end-stage liver disease; HCC – hepatocellular carcinoma. | ||||






